Search research articles
Contact Us
Filters
Showing results (281-290 of 307) with videos related to
Page
of 31
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2016
An Open-Label, Dose-Escalation Phase I Study of Anti-TYRP1 Monoclonal Antibody IMC-20D7S for Patients with Relapsed or Refractory Melanoma
Danny N Khalil, Michael A Postow, Nageatte Ibrahim, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 2, 2025
Lymphotropic Virotherapy Engages DC and High Endothelial Venule Inflammation to Mediate Cancer <i>In Situ</i> Vaccination
Andrea L Ludwig, Zachary P McKay, Griffin P Carter, et al.
Cancer Research
|
December 26, 2003
A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo
Douglas Burtrum, Zhenping Zhu, Dan Lu, et al.
Oral Oncology
|
December 12, 2018
The genomic landscape of UM-SCC oral cavity squamous cell carcinoma cell lines
Megan L Ludwig, Aditi Kulkarni, Andrew C Birkeland, et al.
Cancer Immunology Research
|
November 21, 2025
Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration
Andrea L Ludwig, Zachary P McKay, Griffin P Carter, et al.
Cancer Research
|
October 3, 2007
Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics
Yili Yang, Jirouta Kitagaki, Ren-Ming Dai, et al.
Stem Cell Reports
|
July 25, 2020
Imaging Transplanted Photoreceptors in Living Nonhuman Primates with Single-Cell Resolution
Ebrahim Aboualizadeh, M Joseph Phillips, Juliette E McGregor, et al.
Neoplasia (New York, N.Y.)
|
June 2, 2009
Development of a fully human anti-PDGFRbeta antibody that suppresses growth of human tumor xenografts and enhances antitumor activity of an anti-VEGFR2 antibody
Juqun Shen, Marie Danielle Vil, Marie Prewett, et al.
Head & Neck
|
February 28, 2022
Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma
Nicole L Michmerhuizen, Megan L Ludwig, Andrew C Birkeland, et al.
Journal for Immunotherapy of Cancer
|
May 2, 2018
Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054
Yiwen Li, Carmine Carpenito, George Wang, et al.
Page
of 31
Search research articles
Search
Showing results (281-290 of 307) with videos related to
Sort By:
Page
of 31
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2016
An Open-Label, Dose-Escalation Phase I Study of Anti-TYRP1 Monoclonal Antibody IMC-20D7S for Patients with Relapsed or Refractory Melanoma
Danny N Khalil, Michael A Postow, Nageatte Ibrahim, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 2, 2025
Lymphotropic Virotherapy Engages DC and High Endothelial Venule Inflammation to Mediate Cancer <i>In Situ</i> Vaccination
Andrea L Ludwig, Zachary P McKay, Griffin P Carter, et al.
Cancer Research
|
December 26, 2003
A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo
Douglas Burtrum, Zhenping Zhu, Dan Lu, et al.
Oral Oncology
|
December 12, 2018
The genomic landscape of UM-SCC oral cavity squamous cell carcinoma cell lines
Megan L Ludwig, Aditi Kulkarni, Andrew C Birkeland, et al.
Cancer Immunology Research
|
November 21, 2025
Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration
Andrea L Ludwig, Zachary P McKay, Griffin P Carter, et al.
Cancer Research
|
October 3, 2007
Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics
Yili Yang, Jirouta Kitagaki, Ren-Ming Dai, et al.
Stem Cell Reports
|
July 25, 2020
Imaging Transplanted Photoreceptors in Living Nonhuman Primates with Single-Cell Resolution
Ebrahim Aboualizadeh, M Joseph Phillips, Juliette E McGregor, et al.
Neoplasia (New York, N.Y.)
|
June 2, 2009
Development of a fully human anti-PDGFRbeta antibody that suppresses growth of human tumor xenografts and enhances antitumor activity of an anti-VEGFR2 antibody
Juqun Shen, Marie Danielle Vil, Marie Prewett, et al.
Head & Neck
|
February 28, 2022
Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma
Nicole L Michmerhuizen, Megan L Ludwig, Andrew C Birkeland, et al.
Journal for Immunotherapy of Cancer
|
May 2, 2018
Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054
Yiwen Li, Carmine Carpenito, George Wang, et al.
Page
of 31